🎓 Expert Commentary / Peer Perspective
As more transgender and gender-diverse individuals pursue pregnancy and parenthood, clinicians are encountering a growing need for reproductive and obstetric care that is both clinically competent and gender affirming. Available evidence remains limited, particularly regarding pregnancy outcomes and long-term maternal and neonatal health.
Clinical Considerations
- Transgender men and nonbinary individuals assigned female sex at birth may conceive and carry healthy pregnancies.
- Current evidence regarding pregnancy outcomes, hypertensive disorders, preterm birth, and peripartum mental health remains limited.
- Testosterone suppresses ovulation but is not considered reliable contraception, and pregnancy may occur while therapy continues.
- Testosterone discontinuation is generally recommended during pregnancy because of theoretical fetal and placental concerns.
- Gender dysphoria may worsen during pregnancy, making affirming communication and individualized care important considerations.
- Research participation and outcome reporting remain limited, creating substantial evidence gaps across reproductive medicine.
Practice Applications
- Avoid assumptions regarding gender identity, reproductive goals, or sexual practices.
- Use patients’ chosen names, pronouns, and preferred terminology.
- Discuss fertility planning, contraception, and pregnancy intentions before testosterone initiation when appropriate.
- Recognize that testosterone does not eliminate pregnancy risk.
- Support coordinated postpartum transitions back to affirming primary care and gynecologic services.
- Include partners, family members, and support persons according to patient preferences.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS